PKM and ovarian cancer: Cryptotanshinone directly binds to PKM2, inhibiting its expression in ovarian cancer cells, thereby suppressing both aerobic glycolysis and oxidative phosphorylation (OXPHOS), leading to cell growth inhibition and apoptosis induction (138).